Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol vs propofol plus low-dose sufentanil for suppressing uterine dilation reaction in hysteroscopy
ChiCTR2200065954Phase 4Not yet recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Nov 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ciprofol, propofol and sufentanil in None (2 arms), sponsored by Women's Hospital, Zhejiang University School of Medicine. Primary endpoint: Positive reaction during uterine dilation. Planned start Nov 2022; status: not yet recruiting.
02
Drugs
ciprofolpropofolsufentanil
Beyond the preview
Go deeper on ChiCTR2200065954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200065954.